Healthcare Costs Associated with Complications in Patients with Type 2 Diabetes among 1.85 Million Adults in Beijing, China

We aimed to provide reliable regression estimates of expenditures associated with various complications in type 2 diabetics in China. In total, 1,859,039 type 2 diabetes patients with complications were obtained from the Beijing Medical Claim Data for Employees database from 2008 to 2016. We estimat...

Full description

Saved in:
Bibliographic Details
Published in:International journal of environmental research and public health 2021-04, Vol.18 (7), p.3693
Main Authors: Wu, Jun-Hui, Wu, Yao, Wang, Zi-Jing, Wu, Yi-Qun, Wu, Tao, Wang, Meng-Ying, Wang, Xiao-Wen, Wang, Si-Yue, Wang, Jia-Ting, Yu, Huan, Hu, Yong-Hua
Format: Article
Language:English
Subjects:
Adult
Age
Beijing - epidemiology
Cardiovascular disease
Cardiovascular diseases
Cerebrovascular disease
Cerebrovascular diseases
China - epidemiology
Coma
Complications
Consumer Price Index
Costs
Demographics
Developing countries
Diabetes
Diabetes Complications
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - epidemiology
Estimates
Expenditures
Health care
Health Care Costs
Health Expenditures
Health services utilization
Hospitals
Humans
Kidney diseases
LDCs
Normal distribution
Patients
Statistical analysis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We aimed to provide reliable regression estimates of expenditures associated with various complications in type 2 diabetics in China. In total, 1,859,039 type 2 diabetes patients with complications were obtained from the Beijing Medical Claim Data for Employees database from 2008 to 2016. We estimated costs for complications using a generalized estimating equation model adjusted for age, sex, and the incidence of various complications. The average total cost for diabetic patients with complications was 17.12 thousand RMB. Prescribed drugs accounted for 63.4% of costs. We observed a significant increase in costs in the first year after the onset of complications. Compared with costs before the incidence of complications, the additional costs per person in the first year and >1 year after the event would be 10,631.16 RMB and 1150.71 RMB for cardiovascular disease, 1017.62 RMB and 653.82 RMB for cerebrovascular disease, and 301.14 RMB and 624.00 RMB for kidney disease, respectively. The estimated coefficients for outpatient visits were relatively lower than those of inpatient visits. Complications in diabetics exert a significant impact on total healthcare costs in the first year of their onset and in subsequent years. Our estimates may assist policymakers in quantifying the economic burden of diabetes complications.
ISSN:1660-4601
1661-7827
1660-4601
DOI:10.3390/ijerph18073693